BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Baxano Names George A. Harter, Jr. as Chief Financial Officer


2/15/2011 7:17:41 AM

SAN JOSE, Calif., Feb. 15, 2011 /PRNewswire/ -- Baxano, Inc. (www.baxano.com) today announced the addition of George A. Harter, Jr. to the executive team at Baxano, Inc. As Chief Financial Officer, Mr. Harter will be responsible for Finance, Administration and Human Resources.

Mr. Harter served as the Chief Financial Officer for Acclarent, Inc. from 2005 to 2011, through its acquisition by Johnson & Johnson. From September 2003 to April 2005, Mr. Harter served as Chief Financial Officer for Velocimed, an interventional cardiology company. Prior to Velocimed, Mr. Harter held roles at other health care companies including Boston Scientific. Mr. Harter received his B.A. in Economics from the University of California, Los Angeles and his M.B.A. from Case Western Reserve University.

"George is a key senior executive hire who adds tremendous credibility to our already strong team," said Tony Recupero, President and CEO of Baxano, Inc. "In 2011, our focus on will be on rapidly growing our base of clinical experience. With his impressive background establishing and growing financial and operational systems, he will play a key role in our continuing full commercial launch of the iO-Flex System."

"Baxano's less invasive iO-Flex System holds great promise for many patients suffering from spinal stenosis and provides a cost-effective treatment alternative to health care providers and insurers. I am excited to join Baxano as they bring this compelling technology to market and look forward to leveraging my experience to build another robust commercial-stage medical device company," said Mr. Harter.

About Baxano, Inc.

Based in San Jose, CA, Baxano, Inc., (www.BAXANO.com) is focused on developing innovative solutions that restore spine function, preserve healthy tissue, and enable a better quality of life for patients. Baxano, Inc. is the developer of the iO-Flex System which is an advancement in surgical technology for central, lateral recess and foraminal lumbar stenosis. This unique technology uses thin, flexible instruments through an open exposure or a minimally invasive tube to provide precision lumbar decompression from the "inside out" ("iO"). This "over the wire" approach allows surgeons to address targeted impinging tissue with a non-implant, direct decompression, while preserving facet joint integrity. Up to four nerve roots may be decompressed through a single-point access using this system.

Note: Baxano and iO-Flex are trademarks and service marks of Baxano, Inc.

SOURCE Baxano, Inc.



Read at BioSpace.com

Baxano
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES